MGMT and glioblastoma: In a study conducted by Yang and colleagues in 2022, the detection of methylation levels in the O6-methylguanine-DNA methyltransferase (MGMT) gene emerged as a critical endeavor for the diagnosis, prognosis, and treatment of glioblastoma.